Nexcella CAR T-Cell Therapy Amyloidosis Trial Yields Promising Safety, Efficacy Data
At ASGCT's annual meeting, researchers shared data suggesting that the autologous cell therapy could benefit patients with the rare, multiple myeloma-associated disease.
Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.
Nucleix Bladder EpiCheck Cancer Liquid Biopsy Test Gets FDA 510(k) Clearance
The DNA methylation-based urine PCR test is cleared for monitoring patients diagnosed with non-muscle invasive bladder cancer for recurrence.
OncoHost Licenses Biosensing Technology From BGN Technologies to Predict Immunotherapy Response
The Immuno-checkpoint Artificial Reporter platform has shown in studies to predict patient response to anti-PD-1 therapies across all cancer types.
Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells
The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test.